Andrew King
2020
In 2020, Andrew King earned a total compensation of $2M as Chief Scientific Officer at Aduro BioTech.
Compensation breakdown
| Non-Equity Incentive Plan | $96,135 |
|---|---|
| Option Awards | $1,146,705 |
| Salary | $301,600 |
| Stock Awards | $449,820 |
| Other | $2,000 |
| Total | $1,996,260 |
King received $1.1M in option awards, accounting for 57% of the total pay in 2020.
King also received $96.1K in non-equity incentive plan, $301.6K in salary, $449.8K in stock awards and $2K in other compensation.
Rankings
In 2020, Andrew King's compensation ranked 5,522nd out of 13,090 executives tracked by ExecPay. In other words, King earned more than 57.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,522 out of 13,090 | 58th |
Division Manufacturing | 2,275 out of 5,621 | 60th |
Major group Chemicals And Allied Products | 909 out of 2,254 | 60th |
Industry group Drugs | 786 out of 1,954 | 60th |
Industry Pharmaceutical Preparations | 585 out of 1,459 | 60th |
Source: SEC filing on April 14, 2022.
King's colleagues
We found four more compensation records of executives who worked with Andrew King at Aduro BioTech in 2020.